Prof. Javad Parvizi, MD

Prof. Javad Parvizi, MD, FRCS is an orthopedic surgeon in the Orthopedics & Joint Center at Acibadem Maslak Hospital in İstanbul, Türkiye, where he co-founded the International Joint Center (IJC) in 2024, and Professor of Orthopedic Surgery at Acıbadem University. His practice covers hip and knee replacement, revision of failed joint replacements, periprosthetic joint infection and hip preservation surgery in young adults. He has more than 30 years of experience in medicine and consults in Turkish and English.

Dr. Parvizi graduated in medicine from the University of Sheffield in the United Kingdom (MB ChB, 1991), completed his early surgical training in Sheffield and Newcastle upon Tyne, and became a Fellow of the Royal College of Surgeons of England (FRCS). He then moved to the Mayo Clinic in Rochester, Minnesota, where he completed his residency in orthopedic surgery (1997–2002) and a Master of Science in orthopedics at the Mayo Foundation. In 2002–2003 he held the Hip Society–Müller Foundation Fellowship in adult reconstruction at the Inselspital, University of Bern, Switzerland, training in joint-preserving hip surgery with Prof. Reinhold Ganz.

From 2003 to 2023 he worked in Philadelphia at the Rothman Orthopaedic Institute and Thomas Jefferson University, where he became Professor of Orthopedic Surgery in 2008 and held the James Edwards Chair at Sidney Kimmel Medical College. He joined Acıbadem Healthcare Group and Acıbadem University in 2024.

He served as the 33rd President of the American Association of Hip and Knee Surgeons (2023–2024), President of the Musculoskeletal Infection Society (2013) and President of the Eastern Orthopaedic Association (2018). He co-chaired the International Consensus Meetings on periprosthetic joint infection and musculoskeletal infection held in Philadelphia in 2013 and 2018, and founded and chaired the 2025 meeting in İstanbul. PubMed lists 987 publications under his name (September 2026). They include the Musculoskeletal Infection Society definition of periprosthetic joint infection (2011) and its evidence-based 2018 revision, studies of low-dose aspirin for the prevention of blood clots after joint replacement, and the 2003 paper with Prof. Ganz that described femoroacetabular impingement as a cause of hip osteoarthritis. His research has been funded by the National Institutes of Health, the United States Department of Defense, the Orthopaedic Research and Education Foundation, the Musculoskeletal Transplant Foundation and the Arthritis Foundation. He is a named inventor on patents for the diagnosis of periprosthetic joint infection, and has written and edited orthopedic textbooks, among them High Yield Orthopaedics and The Hip: Preservation, Replacement and Revision.

Clinical focus

Dr. Parvizi’s practice centers on adult reconstruction of the hip and knee. He performs hip replacement and knee arthroplasty for joints damaged by hip osteoarthritis, knee osteoarthritis, avascular necrosis, inflammatory arthritis or fracture, and complex joint reconstruction when an earlier implant has loosened, worn or failed.

A large part of his clinical and research work concerns periprosthetic joint infection, an infection around a hip or knee implant. Diagnosis combines the clinical picture with blood tests, analysis of joint fluid and cultures, following the published consensus criteria; treatment ranges from surgical cleaning with retention of the implant to one-stage or two-stage exchange of the prosthesis, together with targeted antibiotics chosen with infectious disease specialists. Which approach is suitable depends on the organism, the duration of the infection, the condition of the bone and soft tissue, and the patient’s general health.

For younger adults he offers hip preservation surgery, which repairs the patient’s own hip instead of replacing it. This includes treatment of femoroacetabular impingement and labral tears, and hip dysplasia surgery such as periacetabular osteotomy for hip dysplasia in adults. Whether a surgical or non-surgical approach is appropriate depends on the individual patient’s condition, imaging findings and overall health, and is decided only after a clinical assessment.

How Dr. Parvizi works with international patients

Dr. Parvizi consults in Turkish and English. The hospital’s international patient team coordinates the transfer of medical reports and imaging, arranges appointments, and helps organize the sequence of visits for patients traveling from abroad. A first consultation typically covers a review of the patient’s medical history, previous reports and imaging, a clinical examination where relevant, and a discussion of possible treatment options and what further investigations may be needed. Video consultation is available for international patients who wish to speak with Dr. Parvizi before traveling.